Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 1/2 2Phase 4 1Phase 3 1

Status

Unknown 2Terminated 2Withdrawn 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 2Thoracic 1Plasma cell 1Breast 1

Conditions

Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Lung Neoplasms 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Chloroquine × Clear all
NCT01894633 2024-01-24

CLQ

Instituto Nacional de Cancerologia de Mexico

Phase 2 Terminated
73 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT02432417 2023-11-18

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

Maastricht Radiation Oncology

Phase 2 Withdrawn
CNS

Glioblastoma

NCT05647330 2022-12-12

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Henan Cancer Hospital

Phase 2 Unknown
55 enrolled
Thoracic

Lung Neoplasms

NCT01438177 2020-02-24

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

NYU Langone Health

Phase 2 Terminated
11 enrolled 9 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02333890 2016-11-18

CUBiC

Ottawa Hospital Research Institute

Phase 2 Unknown
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡